Special Survey for Patients With Type 1 or Type 2 Diabetes

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: insulin aspart

Study type: Observational

Funder types: Industry

Identifiers

NCT01538589

BIASP-1943

Details and patient eligibility

About

This study is conducted in Japan. The aim of this study is to evaluate the incidence of severe hypoglycaemia under normal clinical practice.

Enrollment: 1,582 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with no treatment history of insulin aspart (NovoRapid®)

Trial design

1,582 participants in 1 patient group

Insulin aspart users

Treatment:

Drug: insulin aspart